According to Chemed's latest financial reports the company has a price-to-book ratio of 8.17.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 9.50 | -27.28% |
2021-12-31 | 13.1 | 38.61% |
2020-12-31 | 9.43 | -2.19% |
2019-12-31 | 9.64 | 26.75% |
2018-12-31 | 7.60 | 5.9% |
2017-12-31 | 7.18 | 44.61% |
2016-12-31 | 4.97 | 1.28% |
2015-12-31 | 4.90 | 23.98% |
2014-12-31 | 3.95 | 31.75% |
2013-12-31 | 3.00 | 7.04% |
2012-12-31 | 2.80 | 13.94% |
2011-12-31 | 2.46 | -15.85% |
2010-12-31 | 2.92 | 28.64% |
2009-12-31 | 2.27 | -5.04% |
2008-12-31 | 2.39 | -34.85% |
2007-12-31 | 3.67 | 62.14% |
2006-12-31 | 2.27 | -32.53% |
2005-12-31 | 3.36 | 31.81% |
2004-12-31 | 2.55 | 7.35% |
2003-12-31 | 2.37 | 37.16% |
2002-12-31 | 1.73 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | 3.10 | -62.04% | ๐บ๐ธ USA |
![]() Amedisys AMED | 2.89 | -64.65% | ๐บ๐ธ USA |
![]() Balchem BCPC | 3.94 | -51.77% | ๐บ๐ธ USA |
![]() Sensient Technologies
SXT | 2.27 | -72.25% | ๐บ๐ธ USA |